Loading...
G3139 (Genasense) in Patients With Advanced Merkel Cell Carcinoma
OBJECTIVES: Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine malignancy of the skin. Preclinical studies have identified up-regulation of the critical antiapoptosis gene bcl-2 in MCC. We conducted a multicenter phase II trial of the novel bcl-2 antisense agent (G3139, Genasense) in p...
Na minha lista:
| Udgivet i: | Am J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311264/ https://ncbi.nlm.nih.gov/pubmed/19307957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e31817eebf8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|